Feature Channels:

Article ID: 689968

A hypertonic grip expander for individuals with cerebral palsy and stroke patients, a chair for students on the autism spectrum, and an independent lifting device for quadriplegic individuals are the designs created by teams of undergraduate students from colleges and universities in the Northeast during the inaugural Engineering Innovation for Society (EIS—pronounced “ice”) student design competition.

Article ID: 689723

There’s a cause of dementia that can sometimes be reversed, but it’s often not diagnosed because the symptoms are so similar to those of other disorders. Now researchers say a simple walking test may be able to accurately diagnose the disease, according to a study published the February 21, 2018, online issue of Neurology®, the medical journal of the American Academy of Neurology.

Article ID: 689904

Fred A. Kobylarz, MD, associate professor of family medicine and community health at Rutgers Robert Wood Johnson Medical School, is an expert in dementia and Alzheimer’s disease, and offers caregivers and family members information on diagnoses and symptoms, as well how to best improve the quality of life for their family member.

Article ID: 689876

For couples with decades of shared memories, a partner’s decline in the ability to communicate because of dementia is frightening and frustrating. Communication strategies they’ve used before simply don’t work anymore. By getting creative, an in-home intervention to support couples affected by dementia is showing that “practice does make perfect,” both for the caregiver and the care receiver or person with dementia, and can improve their communication behaviors in just 10 weeks.

Article ID: 689862

Axonal and dendritic proteins embedded in the membrane at either end – called transmembrane proteins – are built in the same cellular factory and travel on the same cellular highway. But for the cell to function property, they must be delivered to the correct domain. So how does the cell regulate that voyage?

Article ID: 689801

A therapeutic target to preserve vision in glaucoma patients could have treatment ramifications for age-related neurodegenerative disorders like Alzheimer’s and Parkinson’s, according to findings released today in the Proceedings of the National Academy of Sciences (PNAS).

Article ID: 689772

The pursuit of the usual suspect in Alzheimer's research may be distracting from a more direct culprit in the disease, according to a study that analyzed data from 51 published experiments. P-tau looked a good bit more culpable than amyloid-beta plaque.

Article ID: 689697

Aging or impaired brains can once again form lasting memories if an enzyme that applies the brakes too hard on a key gene is lifted, according to University of California, Irvine neurobiologists.

Article ID: 688270

How do you explain to a child that Grandpa or Grandma has Alzheimer’s disease?

Article ID: 689613

A drug used to slow cognitive decline in Alzheimer's disease could offer clues on how drugs might one day be able to reverse brain changes that affect learning and memory in teens and young adults who binge drink.